{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:35:33Z","timestamp":1794638133492,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670231"],"award-info":[{"award-number":["81670231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900355"],"award-info":[{"award-number":["81900355"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41418-020-0523-2","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T17:03:07Z","timestamp":1583427787000},"page":"2605-2619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling"],"prefix":"10.1038","volume":"27","author":[{"given":"Naijin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"523_CR1","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1056\/NEJMra021498","volume":"348","author":"M Jessup","year":"2003","unstructured":"Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007\u201318.","journal-title":"N Engl J Med"},{"key":"523_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jchf.2019.06.004","volume":"7","author":"A Aimo","year":"2019","unstructured":"Aimo A, Gaggin HK, Barison A, Emdin M, Januzzi JL Jr. Imaging, biomarker, and clinical predictors of cardiac remodeling in heart failure with reduced ejection fraction. JACC Heart Fail. 2019;7:782\u201394.","journal-title":"JACC Heart Fail"},{"key":"523_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12012-018-9462-2","volume":"18","author":"RJ Henning","year":"2018","unstructured":"Henning RJ, Bourgeois M, Harbison RD. Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors: mechanisms of action and role in cardiovascular disorders. Cardiovasc Toxicol. 2018;18:493\u2013506.","journal-title":"Cardiovasc Toxicol"},{"key":"523_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1108-6","volume":"9","author":"C Wang","year":"2018","unstructured":"Wang C, Xu W, Zhang Y, Zhang F, Huang K. PARP1 promote autophagy in cardiomyocytes via modulating FoxO3a transcription. Cell Death Dis. 2018;9:1047.","journal-title":"Cell Death Dis"},{"key":"523_CR5","doi-asserted-by":"publisher","first-page":"e1007065","DOI":"10.1371\/journal.ppat.1007065","volume":"14","author":"JJ Wen","year":"2018","unstructured":"Wen JJ, Yin YW, Garg NJ. PARP1 depletion improves mitochondrial and heart function in Chagas disease: effects on POLG dependent mtDNA maintenance. PLoS Pathog. 2018;14:e1007065.","journal-title":"PLoS Pathog"},{"key":"523_CR6","doi-asserted-by":"publisher","first-page":"H486","DOI":"10.1152\/ajpheart.00437.2004","volume":"288","author":"JB Pillai","year":"2005","unstructured":"Pillai JB, Russell HM, Raman J, Jeevanandam V, Gupta MP. Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure. Am J Physiol Heart Circ Physiol. 2005;288:H486\u201396.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"523_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/aps.2016.159","volume":"38","author":"GS Feng","year":"2017","unstructured":"Feng GS, Zhu CG, Li ZM, Wang PX, Huang Y, Liu M, et al. Synthesis of the novel PARP-1 inhibitor AG-690\/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling. Acta Pharm Sin. 2017;38:638\u201350.","journal-title":"Acta Pharm Sin"},{"key":"523_CR8","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.bbamcr.2016.09.019","volume":"1863","author":"J Lu","year":"2016","unstructured":"Lu J, Zhang R, Hong H, Yang Z, Sun D, Sun S, et al. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy. Biochim Biophys Acta. 2016;1863:3027\u201339.","journal-title":"Biochim Biophys Acta"},{"key":"523_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCRESAHA.118.312497","volume":"123","author":"W Zhang","year":"2018","unstructured":"Zhang W, Song M, Qu J, Liu GH. Epigenetic modifications in cardiovascular aging and diseases. Circ Res. 2018;123:773\u201386.","journal-title":"Circ Res"},{"key":"523_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yjmcc.2015.05.004","volume":"84","author":"K Nishida","year":"2015","unstructured":"Nishida K, Yamaguchi O, Otsu K. Degradation systems in heart failure. J Mol Cell Cardiol. 2015;84:212\u201322.","journal-title":"J Mol Cell Cardiol"},{"key":"523_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cell.2016.03.003","volume":"165","author":"FE Morreale","year":"2016","unstructured":"Morreale FE, Walden H. Types of ubiquitin ligases. Cell. 2016;165:248.","journal-title":"Cell"},{"key":"523_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/ncb2134","volume":"13","author":"W Zou","year":"2011","unstructured":"Zou W, Chen X, Shim JH, Huang Z, Brady N, Hu D, et al. The E3 ubiquitin ligase Wwp2 regulates craniofacial development through mono-ubiquitylation of goosecoid. Nat Cell Biol. 2011;13:59\u201365.","journal-title":"Nat Cell Biol"},{"key":"523_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.molcel.2017.03.020","volume":"66","author":"Z Chen","year":"2017","unstructured":"Chen Z, Jiang H, Xu W, Li X, Dempsey DR, Zhang X, et al. A tunable brake for HECT ubiquitin ligases. Mol Cell. 2017;66:345\u201357.","journal-title":"Mol Cell"},{"key":"523_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ncb2240","volume":"13","author":"S Maddika","year":"2011","unstructured":"Maddika S, Kavela S, Rani N, Palicharla VR, Pokorny JL, Sarkaria JN, et al. WWP2 is an E3 ubiquitin ligase for PTEN. Nat Cell Biol. 2011;13:728\u201333.","journal-title":"Nat Cell Biol"},{"key":"523_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s12253-014-9838-y","volume":"20","author":"W Chen","year":"2014","unstructured":"Chen W, Jiang X, Luo Z. WWP2: a multifunctional ubiquitin ligase gene. Pathol Oncol Res. 2014;20:799\u2013803.","journal-title":"Pathol Oncol Res"},{"key":"523_CR16","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1128\/MCB.01667-06","volume":"27","author":"H Li","year":"2007","unstructured":"Li H, Zhang Z, Wang B, Zhang J, Zhao Y, Jin Y. Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells. Mol Cell Biol. 2007;27:5296\u2013305.","journal-title":"Mol Cell Biol"},{"key":"523_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1536\/ihj.18-226","volume":"60","author":"N Ishizue","year":"2019","unstructured":"Ishizue N, Niwano S, Niwano H, Oikawa J, Nakamura H, Hashikata T, et al. Linagliptin suppresses electrical and structural remodeling in the isoproterenol induced myocardial injury model. Int Heart J. 2019;60:411\u20138.","journal-title":"Int Heart J"},{"key":"523_CR18","doi-asserted-by":"publisher","unstructured":"Hu H, Jiang M, Cao Y, Zhang Z, Jiang B, Tian F, et al. HuR regulates phospholamban expression in isoproterenol-induced cardiac remodeling. Cardiovasc Res. 2019;cvz205. https:\/\/doi.org\/10.1093\/cvr\/cvz205. [Epub ahead of print].","DOI":"10.1093\/cvr\/cvz205"},{"key":"523_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1172\/JCI58227","volume":"122","author":"SA Goonasekera","year":"2012","unstructured":"Goonasekera SA, Hammer K, Auger-Messier M, Bodi I, Chen X, Zhang H, et al. Decreased cardiac L-type Ca2+ channel activity induces hypertrophy and heart failure in mice. J Clin Invest. 2012;122:280\u201390.","journal-title":"J Clin Invest"},{"key":"523_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1527-3466.2007.00018.x","volume":"25","author":"P Pacher","year":"2007","unstructured":"Pacher P, Szab\u00f3 C. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev. 2007;25:235\u201360.","journal-title":"Cardiovasc Drug Rev"},{"key":"523_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrd1718","volume":"4","author":"P Jagtap","year":"2005","unstructured":"Jagtap P, Szab\u00f3 C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Disco. 2005;4:421\u201340.","journal-title":"Nat Rev Drug Disco"},{"key":"523_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/14756366.2011.642373","volume":"28","author":"K Yamazaki","year":"2013","unstructured":"Yamazaki K, Tanaka S, Sakata R, Miwa S, Oriyanhan W, Takaba K, et al. Protective effect of cardioplegia with poly (ADP-ribose) polymerase-1 inhibitor against myocardial ischemia-reperfusion injury: in vitro study of isolated rat heart model. J Enzym Inhib Med Chem. 2013;28:143\u20137.","journal-title":"J Enzym Inhib Med Chem"},{"key":"523_CR23","doi-asserted-by":"publisher","first-page":"H1408","DOI":"10.1152\/ajpheart.00953.2003","volume":"286","author":"B Zingarelli","year":"2004","unstructured":"Zingarelli B, Hake PW, O\u2019Connor M, Denenberg A, Wong HR, Kong S, et al. Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1. Am J Physiol Heart Circ Physiol. 2004;286:H1408\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"523_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1756-8935-3-22","volume":"3","author":"BM Zee","year":"2010","unstructured":"Zee BM, Levin RS, DiMaggio PA, Garcia BA. Global turnover of histone post-translational modifications and variants in human cells. Epigenetics Chromatin. 2010;3:22.","journal-title":"Epigenetics Chromatin"},{"key":"523_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/gm424","volume":"5","author":"KA Liddy","year":"2013","unstructured":"Liddy KA, White MY, Cordwell SJ. Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics. Genome Med. 2013;5:20.","journal-title":"Genome Med"},{"key":"523_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.yjmcc.2013.10.015","volume":"66","author":"D Fessart","year":"2014","unstructured":"Fessart D, Martin-Negrier ML, Claverol S, Thiolat ML, Crevel H, Toussaint C, et al. Proteomic remodeling of proteasome in right heart failure. J Mol Cell Cardiol. 2014;66:41\u201352.","journal-title":"J Mol Cell Cardiol"},{"key":"523_CR27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.healun.2017.02.012","volume":"36","author":"YD Barac","year":"2017","unstructured":"Barac YD, Emrich F, Krutzwakd-Josefson E, Schrepfer S, Sampaio LC, Willerson JT, et al. The ubiquitin-proteasome system: a potential therapeutic target for heart failure. J Heart Lung Transpl. 2017;36:708\u201314.","journal-title":"J Heart Lung Transpl"},{"key":"523_CR28","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1073\/pnas.1220271110","volume":"110","author":"Y Yang","year":"2013","unstructured":"Yang Y, Liao B, Wang S, Yan B, Jin Y, Shu HB, et al. E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation. Proc Natl Acad Sci USA. 2013;110:5115\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"523_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/cr.2009.136","volume":"20","author":"B Liao","year":"2010","unstructured":"Liao B, Jin Y. Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner. Cell Res. 2010;20:332\u201344.","journal-title":"Cell Res"},{"key":"523_CR30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41590-018-0137-8","volume":"19","author":"D Aki","year":"2018","unstructured":"Aki D, Li H, Zhang W, Zheng M, Elly C, Lee JH, et al. The E3 ligases Itch and WWP2 cooperate to limit TH2 differentiation by enhancing signaling through the TCR. Nat Immunol. 2018;19:766\u201375.","journal-title":"Nat Immunol"},{"key":"523_CR31","doi-asserted-by":"publisher","first-page":"18308","DOI":"10.1073\/pnas.0606526103","volume":"103","author":"SA Andrabi","year":"2006","unstructured":"Andrabi SA, Kim NS, Yu SW, Wang H, Koh DW, Sasaki M, et al. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci USA. 2006;103:18308\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"523_CR32","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.mam.2013.01.007","volume":"34","author":"L Vir\u00e1g","year":"2013","unstructured":"Vir\u00e1g L, Robaszkiewicz A, Rodriguez-Vargas JM, Oliver FJ. Poly(ADP-ribose) signaling in cell death. Mol Asp Med. 2013;34:1153\u201367.","journal-title":"Mol Asp Med"},{"key":"523_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm.4032","volume":"22","author":"Y Du","year":"2016","unstructured":"Du Y, Yamaguchi H, Wei Y, Hsu JL, Wang HL, Hsu YH, et al. Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors. Nat Med. 2016;22:194\u2013201.","journal-title":"Nat Med"},{"key":"523_CR34","doi-asserted-by":"publisher","first-page":"40450","DOI":"10.1074\/jbc.M507553200","volume":"280","author":"PO Hassa","year":"2005","unstructured":"Hassa PO, Haenni SS, Buerki C, Meier NI, Lane WS, Owen H, et al. Acetylation of poly(ADP-ribose) polymerase-1 by p300\/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem. 2005;280:40450\u201364.","journal-title":"J Biol Chem"},{"key":"523_CR35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.tips.2006.10.003","volume":"27","author":"C Szabo","year":"2006","unstructured":"Szabo C, Pacher P, Swanson RA. Novel modulators of poly(ADP-ribose) polymerase. Trends Pharm Sci. 2006;27:626\u201330.","journal-title":"Trends Pharm Sci"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41418-020-0523-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41418-020-0523-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41418-020-0523-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:46Z","timestamp":1684617346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-0523-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["523"],"URL":"https:\/\/doi.org\/10.1038\/s41418-020-0523-2","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}